This collection
expired in 5/96. Therefore, any collections since that date have
been in violation of the Paperwork Reduction Act. The collection is
approved on the condition that FDA add a burden statement, in
accordance with the Paperwork Reduction Act, to the form. FDA shall
send the revised form to OMB prior to its release.
Inventory as of this Action
Requested
Previously Approved
11/30/2000
11/30/2000
2,800
0
0
448
0
0
0
0
0
FDA-2567 is completed by manufacturers
of biological products when applying for a license for new product,
when updating labeling information on a licensed biological
product, or when an amended label or package insert is generated
for a licensed product.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.